Streptococcus pneumoniae genomic datasets from an Indian population describing pre-vaccine evolutionary epidemiology using a whole genome sequencing approach
- PMID: 34494953
- PMCID: PMC8715438
- DOI: 10.1099/mgen.0.000645
Streptococcus pneumoniae genomic datasets from an Indian population describing pre-vaccine evolutionary epidemiology using a whole genome sequencing approach
Abstract
Globally, India has a high burden of pneumococcal disease, and pneumococcal conjugate vaccine (PCV) has been rolled out in different phases across the country since May 2017 in the national infant immunization programme (NIP). To provide a baseline for assessing the impact of the vaccine on circulating pneumococci in India, genetic characterization of pneumococcal isolates detected prior to introduction of PCV would be helpful. Here we present a population genomic study of 480 Streptococcus pneumoniae isolates collected across India and from all age groups before vaccine introduction (2009-2017), including 294 isolates from pneumococcal disease and 186 collected through nasopharyngeal surveys. Population genetic structure, serotype and antimicrobial susceptibility profile were characterized and predicted from whole-genome sequencing data. Our findings revealed high levels of genetic diversity represented by 110 Global Pneumococcal Sequence Clusters (GPSCs) and 54 serotypes. Serotype 19F and GPSC1 (CC320) was the most common serotype and pneumococcal lineage, respectively. Coverage of PCV13 (Pfizer) and 10-valent Pneumosil (Serum Institute of India) serotypes in age groups of ≤2 and 3-5 years were 63-75 % and 60-69 %, respectively. Coverage of PPV23 (Merck) serotypes in age groups of ≥50 years was 62 % (98/158). Among the top five lineages causing disease, GPSC10 (CC230), which ranked second, is the only lineage that expressed both PCV13 (serotypes 3, 6A, 14, 19A and 19F) and non-PCV13 (7B, 13, 10A, 11A, 13, 15B/C, 22F, 24F) serotypes. It exhibited multidrug resistance and was the largest contributor (17 %, 18/103) of NVTs in the disease-causing population. Overall, 42 % (202/480) of isolates were penicillin-resistant (minimum inhibitory concentration ≥0.12 µg ml-1) and 45 % (217/480) were multidrug-resistant. Nine GPSCs (GPSC1, 6, 9, 10, 13, 16, 43, 91, 376) were penicillin-resistant and among them six were multidrug-resistant. Pneumococci expressing PCV13 serotypes had a higher prevalence of antibiotic resistance. Sequencing of pneumococcal genomes has significantly improved our understanding of the biology of these bacteria. This study, describing the pneumococcal disease and carriage epidemiology pre-PCV introduction, demonstrates that 60-75 % of pneumococcal serotypes in children ≤5 years are covered by PCV13 and Pneumosil. Vaccination against pneumococci is very likely to reduce antibiotic resistance. A multidrug-resistant pneumococcal lineage, GPSC10 (CC230), is a high-risk clone that could mediate serotype replacement.
Keywords: India; S. pneumoniae; genomic dataset; global pneumococcal sequence cluster; pre-vaccine.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures




Similar articles
-
Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study.Lancet Infect Dis. 2019 Jul;19(7):759-769. doi: 10.1016/S1473-3099(19)30297-X. Epub 2019 Jun 10. Lancet Infect Dis. 2019. PMID: 31196809 Free PMC article.
-
Genomic characterization of Streptococcus pneumoniae isolates obtained from carriage and disease among paediatric patients in Addis Ababa, Ethiopia.Microb Genom. 2025 Mar;11(3):001376. doi: 10.1099/mgen.0.001376. Microb Genom. 2025. PMID: 40100271 Free PMC article.
-
Streptococcus pneumoniae carriage, serotypes, genotypes, and antimicrobial resistance trends among children in Portugal, after introduction of PCV13 in National Immunization Program: A cross-sectional study.Vaccine. 2024 Sep 17;42(22):126219. doi: 10.1016/j.vaccine.2024.126219. Epub 2024 Aug 14. Vaccine. 2024. PMID: 39146858
-
CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW.Expert Rev Vaccines. 2021 Jan;20(1):45-57. doi: 10.1080/14760584.2021.1873136. Epub 2021 Feb 17. Expert Rev Vaccines. 2021. PMID: 33507135
-
Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review.Vaccine. 2017 Aug 16;35(35 Pt B):4501-4509. doi: 10.1016/j.vaccine.2017.06.079. Epub 2017 Jul 12. Vaccine. 2017. PMID: 28711387
Cited by
-
Pre- & post-vaccine trends in pneumococcal serotypes & antimicrobial resistance patterns.Indian J Med Res. 2024 Sep&Oct;160(3&4):354-361. doi: 10.25259/ijmr_1811_23. Indian J Med Res. 2024. PMID: 39632638 Free PMC article.
-
Effects of Pneumococcal Vaccination in Children Under Five Years of Age in the Democratic Republic of Congo: A Systematic Review.Vaccines (Basel). 2025 May 31;13(6):603. doi: 10.3390/vaccines13060603. Vaccines (Basel). 2025. PMID: 40573934 Free PMC article. Review.
-
Comparison of next generation technologies and bioinformatics pipelines for capsular typing of Streptococcus pneumoniae.J Clin Microbiol. 2023 Dec 19;61(12):e0074123. doi: 10.1128/jcm.00741-23. Epub 2023 Nov 21. J Clin Microbiol. 2023. PMID: 38092657 Free PMC article.
-
A Multicenter Evaluation of Overall Susceptibility and Antimicrobial Resistance Among Streptococcus pneumoniae Isolates.Cureus. 2023 Jul 17;15(7):e41984. doi: 10.7759/cureus.41984. eCollection 2023 Jul. Cureus. 2023. PMID: 37593286 Free PMC article.
-
Genomic analysis and pneumococcal population dynamics across PCV implementation in South Korea, 1997-2023.Microb Genom. 2025 Jul;11(7):001433. doi: 10.1099/mgen.0.001433. Microb Genom. 2025. PMID: 40673903 Free PMC article.
References
-
- Wahl B, O’Brien KL, Greenbaum A, Majumder A, Liu L. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob Health. 2018;6:e744–e757. doi: 10.1016/S2214-109X(18)30247-X. - DOI - PMC - PubMed
-
- Suri S. Reducing infectious diseases in children: Tracking india’s progress and outlining the challenges. 2019. https://www.orfonline.org/wp-content/uploads/2019/04/ORF_Special_Report_...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical